Sulbactam
File:Sulbactam.svg | |
Clinical data | |
---|---|
Routes of administration | Injection |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 1 |
Excretion | Kidneys? |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C8H11NO5S |
Molar mass | 233.243 g/mol |
WikiDoc Resources for Sulbactam |
Articles |
---|
Most recent articles on Sulbactam |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Sulbactam at Clinical Trials.gov Clinical Trials on Sulbactam at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Sulbactam
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Sulbactam Discussion groups on Sulbactam Directions to Hospitals Treating Sulbactam Risk calculators and risk factors for Sulbactam
|
Healthcare Provider Resources |
Causes & Risk Factors for Sulbactam |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Sulbactam is a molecule which is given in combination with beta-lactam antibiotics to inhibit beta-lactamase, an enzyme produced by bacteria that destroys the antibiotics. Sulbactam is an irreversible inhibitor of beta-lactamase; it binds the enzyme and does not allow it to interact with the antibiotic. Sulbactam is able to inhibit the most common forms of beta-lactamase but is not able to interact with the ampC cephalosporinase. Thus, it confers little protection against bacteria such as Pseudomonas aeruginosa, Citrobacter, Enterobacter, and Serratia, which often express this gene. In the United States, sulbactam is combined to form cefoperazone/sulbactam and ampicillin/sulbactam. It does possess some antibacterial activity when administered alone, but it is too weak to have any clinical importance. Its use in the UK is restricted to hospitals.
References
- Singh GS. Beta-lactams in the new millennium. Part-II: cephems, oxacephems, penams and sulbactam. Mini Rev Med Chem. 2004 Jan;4(1):93-109. Review. PMID 14754446
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Beta-lactamase inhibitors